CRI Funded Scientists

Ido Yofe, PhD, Postdoctoral Fellow

Weizmann Institute of Science (Israel)

Area of Research: All Cancers

Cancer treatment is undergoing a revolution with the use of checkpoint immunotherapies. These treatments don’t target the cancer cells themselves, but rather re-invigorate the cells of the immune system to fight and eliminate tumors. However, this isn’t a simple task, as tumors have tricks to defend themselves against these re-activated, “dormant” immune cells, and as a result, these treatments still don’t work for the majority of patients. In addition, it is becoming clearer that many of the immune cells inside tumors can actually protect tumors by suppressing the T cells that target and eliminate cancer cells. 

Therefore, Dr. Yofe’s research aims to use the latest technology to profile each and every cell within the tumor individually, in order to dissect the most subtle features and immune cell interactions found in each patient’s tumor, and understand how immunotherapy treatment alters them. His vision is to create a model for optimized cancer treatments based on specific immune cell populations. Ultimately, Yofe’s work may pave the way for strategies that enable each patient’s tumor to be examined at the single-cell level, and then enable doctors to tailor treatment combinations to individual patients based on their specific tumor’s composition.

Projects and Grants

Single-cell analysis of the tumor-immune ecosystem in human cancers

Weizmann Institute of Science (Israel) | All Cancers | 2019 | Ido Amit, PhD

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.